Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
fatty15 Review
One word carries this entire product, and nutrition science has not granted it.
fatty15
“Essential” Is Doing The SellingThe claim: "C15:0 is the first essential fatty acid to emerge in over 90 years." But essential is a technical term — the body cannot make enough, and absence produces a defined deficiency syndrome. That is why linoleic and alpha-linolenic acid qualify and even EPA and DHA generally do not. No reference intake body has classified C15:0 as essential, and there is no recognised deficiency state.
And the proven claim proves very little: "fatty15 is clinically proven to raise C15:0 levels." Read precisely, that says swallowing C15:0 puts C15:0 in your blood. It is technically accurate and carefully limited — genuine credit for that — but it is the third time in a short run of reviews we have found a company proving a number moves and leaving the reader to supply the benefit.
The benefits are footnoted to a customer poll: better energy, healthier mood and improved health all carry a dagger reading "Based on a survey with 6,243 fatty customers." Disclosing that is more honest than hiding it — and a survey of people who already bought, kept buying, and were asked by the seller is not efficacy evidence. They also sell a C15:0 diagnostic test alongside the supplement.
Fair credit, checked rather than assumed: the FDA disclaimer is present and correctly worded in the footer; patents and peer-reviewed studies pages exist so the work is findable; the Navy dolphin origin is stated rather than obscured; and C15:0 is a genuine fatty acid with a real and growing literature. Our criticism is about the framing and the price, not about hazard.
Affiliate disclosure: GLP1Drugs.org earns 8% of order value — about $9.60 on the $119.95 ninety-day kit — and nothing on our advice, which is that $487 a year buys a great deal more protein, dietitian time or gym membership than it buys hypothesis. Verified 10 August 2026.
Visit fatty15Our Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
2
Fatty Acids Actually Classed Essential
$487
A Year At The Discounted Price
6,243
Customers In The Survey Behind The Claims
$64.95
The Children's Version
What We Verified
Claims and prices quoted from their own homepage and published product data. We checked for the FDA disclaimer specifically and found it present.
The Word Essential Is Doing The Selling
"C15:0 is the first essential fatty acid to emerge in over 90 years." In nutrition, essential is a technical term: the body cannot make enough, and going without produces a defined deficiency syndrome. For fatty acids that means linoleic acid and alpha-linolenic acid. No dietary reference intake body classifies C15:0 as essential
Which Converts A Choice Into A Correction
If a nutrient is essential and you might be short of it, buying is not optional — it is fixing something. Their site invites you to "read the science behind nutritional C15:0 deficiencies" and says low levels "can make our cells more fragile and may accelerate aging." That framing, not the molecule, is the product
"Clinically Proven To Raise C15:0 Levels"
Read that precisely: the supplement is proven to put into your blood the substance you swallowed. That is the least surprising result available and it is not evidence of benefit. It is the same surrogate-marker structure we found selling stem cell counts and NAD+ levels elsewhere
The Benefit Claims Are Footnoted To A Customer Survey
Better energy, healthier mood and overall improved health carry a dagger, and the dagger reads: "Based on a survey with 6,243 fatty customers." Attributing it is more honest than not. A self-reported survey of people who already bought and kept buying is not efficacy evidence
They Also Sell The Test That Finds The Deficiency
The range includes a C15:0 Diagnostic Test alongside the supplement. Selling both the measurement that identifies a need and the product that meets it is a structure worth seeing clearly before you buy either
Patents And Study Counts Are Not Efficacy
"100+ Peer-Reviewed Studies", "60+ Patents", "30+ Awards". Patents establish novelty and legal ownership, not that something works. A count of studies says nothing about what they found, how large they were, or who funded them
The Pattern We Keep Finding
Three companies, three categories, one structure. This is the most useful filter we can offer for the whole supplement aisle.
| Product | What Is Proven | What Is Implied |
|---|---|---|
| fatty15 | Taking C15:0 raises your C15:0 | Cells become less fragile, aging slows |
| Stem cell supplements | Circulating stem cell counts rise by a percentage | Tissue repair, rejuvenation |
| NAD+ products | Taking NAD+ precursors raises NAD+ levels | Cellular energy, healthy aging |
| The question to ask | Is the proven claim about a number in my blood, or about something that happened to me? | |
In every case a real, measurable thing genuinely moves. In every case the step from that movement to a health benefit is taken by the marketing rather than the evidence. See our Stemregen and Luvo Health reviews for the other two.
What $487 A Year Buys Instead
General guidance, not medical advice. We earn nothing on any of the alternatives.
| Spend | Evidence Behind It |
|---|---|
| Adequate protein, properly assessed | Well established for preserving lean mass during weight loss |
| Resistance training, twice a week | The best-supported intervention there is, and $487 covers a year of it |
| A few dietitian consultations | Individualised, and addresses the actual nutritional gaps on these medicines |
| A year of C15:0 | A promising hypothesis and a customer survey |
There is a thin thread of genuine relevance — C15:0's main dietary source is dairy fat, and people eating substantially less consume less of most things. But that only matters if the essentiality premise holds, and that is exactly what has not been established. Our side-effects guide covers the nutritional problems on these medicines that are documented.
Pros & Cons
Pros
- ✓The FDA disclaimer is present and correctly worded in the site footer
- ✓Benefit claims are daggered and the dagger honestly attributes them to a customer survey rather than implying a trial
- ✓"Clinically proven to raise C15:0 levels" is, read literally, an accurate and carefully limited claim
- ✓C15:0 is a real fatty acid with a genuine and growing research literature behind it
- ✓A published patents page and peer-reviewed studies page exist, so the underlying work is at least findable
- ✓A diagnostic test is offered rather than asking you to assume you are deficient
- ✓Pricing is transparent, with the 90-day kit visibly discounted from $149.94 to $119.95
- ✓The company is open about its origin in US Navy dolphin research rather than obscuring it
Cons
- ✕"Essential fatty acid" is not how nutrition authorities classify C15:0, and the word carries enormous persuasive weight
- ✕No dietary reference intake, no defined deficiency syndrome, and no consensus recognition exist for it
- ✕The headline efficacy claim is that it raises the level of the substance you just took
- ✕Benefit claims rest on a survey of existing customers, which is subject to every selection and expectation bias
- ✕The company sells both the deficiency test and the deficiency remedy
- ✕Roughly $487 a year at the discounted 90-day price, or $79.95 for gummies
- ✕A children's version at $64.95 for a nutrient with no established paediatric requirement
- ✕Patent and study counts are presented as though they demonstrate the product works
- ✕Much of the foundational research originates with the company's own founders and affiliates
- ✕C15:0 occurs in dairy fat, so the premise that ordinary eaters are deficient is not established
Our Verdict
2.4 / 5 — a real molecule and a real research programme, resting on a classification nobody official has made.
There is more to credit here than the rating implies, and we checked for each of these rather than assuming. The FDA disclaimer is present and correctly worded in the footer. The benefit claims carry a dagger, and the dagger honestly resolves to "Based on a survey with 6,243 fatty customers" rather than implying a clinical trial — plenty of companies would have left the reader to infer. The central efficacy claim, that fatty15 is "clinically proven to raise C15:0 levels", is technically accurate and carefully bounded; a less scrupulous operator would have claimed the outcome instead of the mechanism. There is a patents page and a peer-reviewed studies page, so the underlying work is findable rather than merely gestured at. The unusual origin in US Navy dolphin research is stated openly rather than obscured. And C15:0 itself is a genuine odd-chain fatty acid, present in dairy fat, with a real and growing literature that we are not dismissing.
The problem is one word, and it carries the entire commercial proposition. "C15:0 is the first essential fatty acid to emerge in over 90 years." In nutrition, essential is not a synonym for important — it is a classification meaning the body cannot synthesise adequate amounts and that going without produces a specific, identifiable deficiency syndrome. That is why vitamin C is essential and scurvy is the consequence. Among fatty acids the established essentials for humans are linoleic acid and alpha-linolenic acid, and it is telling that even EPA and DHA, with vastly more human research behind them than C15:0, are usually described only as conditionally essential. As far as we can establish, no body that sets dietary reference intakes has classified C15:0 as essential, there is no reference intake for it, and there is no recognised deficiency syndrome. That single word transforms the purchase. A supplement is optional; correcting a deficiency in an essential nutrient is not. The site reinforces the frame by inviting readers to "read the science behind nutritional C15:0 deficiencies" and warning that low levels "can make our cells more fragile and may accelerate aging."
Underneath the framing, look at what is actually proven. "Clinically proven to raise C15:0 levels" means that swallowing C15:0 increases the amount of C15:0 in your body. That is very close to the least surprising finding a study could produce; it establishes absorption and nothing else. This is now the third time in a short run of reviews that we have encountered precisely this structure. One company sells supplements proven to raise circulating stem cell counts by a percentage. Another sells NAD+ on the basis that it raises NAD+ levels. Here, C15:0 raises C15:0. In each case something real and measurable genuinely moves, and in each case the step from that movement to a health benefit is taken by the marketing rather than by evidence. We think that is the single most useful filter available for this entire category, and we would encourage readers to apply it everywhere: ask whether the proven claim describes a number in your blood or something that happened to you. Association compounds the issue — observing that people with higher C15:0 have better outcomes does not show that raising yours with a capsule improves anything, because the level may simply mark a diet that contains dairy.
Three further observations. The outcome claims rest on a survey of 6,243 existing customers, and while disclosing that is genuinely more honest than hiding it, such a survey selects at every stage for people who believed, bought, persisted and were asked by the seller — the people who felt nothing and stopped are absent by construction, and self-reported wellbeing after a $119.95 purchase framed as correcting a deficiency is exactly where expectation shapes answers. The company also sells a C15:0 diagnostic test alongside the supplement, which closes a loop in which the same party defines the condition, sells the measurement and sells the remedy; that is worth seeing plainly, particularly when the underlying classification is contested and a "low" result has no agreed clinical interpretation. And the supporting statistics do less than they appear: "60+ Patents" establishes novelty and legal ownership rather than efficacy, and "100+ Peer-Reviewed Studies" is a count that says nothing about size, funding or findings — noting that much of the foundational work originates with the company's own founders and affiliates, which is not disqualifying but is not independent replication either.
On price and on relevance to this site. The ninety-day starter kit lists at $149.94, discounted to $119.95, which annualises to roughly $487; the adult gummies are $79.95 and there is a children's version at $64.95. That last product gives us the most pause: supplementing a child with a nutrient that has no established paediatric requirement, no reference intake and no recognised deficiency state is a decision for a paediatrician, not a website. For readers here, the honest connection is thin — C15:0's principal dietary source is dairy fat and people eating substantially less will consume less of it — but that only matters if the essentiality premise holds, and the premise is precisely what is unestablished. The concrete point is opportunity cost. On a medication where the documented nutritional problems are getting enough protein into a collapsed appetite, staying hydrated when thirst stops signalling, and managing constipation, $487 a year buys a great deal of protein, several dietitian appointments, or a year of the resistance training that actually protects the lean mass you are at risk of losing. We think it is probably harmless and we found no warning letter; we simply do not think it is established as necessary. Our disclosure: 8% commission, about $9.60 on the discounted kit, and nothing at all on the advice above.
Visit fatty15Frequently Asked Questions
What does "essential fatty acid" actually mean?
It is a technical classification with a high bar, and the whole product turns on it. In nutrition, a nutrient is essential when two conditions hold: the body cannot synthesise it in adequate amounts, and its absence from the diet produces a specific, identifiable deficiency syndrome. That is why vitamin C is essential and scurvy is its deficiency disease. For fatty acids specifically, the established essentials for humans are linoleic acid, an omega-6, and alpha-linolenic acid, an omega-3. Everything else is either synthesised in sufficient quantity or lacks a defined deficiency state. Notably, even EPA and DHA — omega-3s with vastly more human research behind them than C15:0 — are generally described as conditionally essential rather than essential, because the body can make some from alpha-linolenic acid. fatty15's site states that "C15:0 is the first essential fatty acid to emerge in over 90 years." As far as we can establish, no body that sets dietary reference intakes has classified C15:0 as essential, there is no reference intake for it, and there is no recognised C15:0 deficiency syndrome. This is not a quibble about vocabulary. If a nutrient is essential, then not taking it is a deficit you are living with, and buying the supplement stops being a discretionary wellness purchase and becomes a correction. That reframing is the most valuable thing the company owns, and it rests on a classification that nutritional science has not made.
Isn't there real research behind C15:0?
Yes, and we want to be fair about that, because dismissing it would be as lazy as accepting the marketing. C15:0, pentadecanoic acid, is a genuine odd-chain saturated fatty acid, it is present in dairy fat and produced to some extent by gut bacteria, and there is a real and growing literature examining associations between circulating odd-chain fatty acid levels and various health measures. Some of that work is interesting. The company's origin story — research emerging from US Navy dolphin health studies — is unusual but not fanciful, and they do not hide it. They publish a patents page and a peer-reviewed studies page, so the underlying work is findable rather than gestured at. What the marketing does with that literature is where we part company. Two things matter here. First, much of the foundational C15:0 work originates with the company's own founders and affiliated researchers, which does not make it wrong but does mean it is not independent replication, and a count of "100+ Peer-Reviewed Studies" tells you nothing about how many were funded by whom, how large they were, or what they actually found. Second, and more fundamentally, association is not the same as benefit from supplementation. Observing that people with higher C15:0 levels have better outcomes does not establish that raising your level by taking a capsule improves yours — the level might be a marker of a dairy-containing diet, or of something else entirely. That step requires a trial with health outcomes, not a trial showing the capsule raises the level.
What is wrong with "clinically proven to raise C15:0 levels"?
Nothing, as a factual statement — and that is precisely the problem. Read it carefully: the claim is that taking a C15:0 supplement raises the amount of C15:0 in your body. That is close to the least surprising result a study could produce. It is the nutritional equivalent of proving that drinking water makes you less thirsty. It tells you the product is absorbed, which is worth knowing, and it tells you nothing whatsoever about whether having more C15:0 makes you healthier. We should give credit where it is due: this is a carefully worded and technically accurate claim, and a less scrupulous company would have written "clinically proven to slow aging." But it sits directly alongside language about cells becoming "more fragile" and aging accelerating, and most readers will not separate the proven part from the implied part. This is now the third time in a short run of reviews that we have found the same structure. One company sells supplements proven to increase circulating stem cell counts. Another sells NAD+ on the basis that it raises NAD+ levels. Here it is C15:0 raising C15:0. In every case a real, measurable thing moves, and in every case the leap from that movement to a health benefit is made by the marketing rather than by the evidence. Once you notice the pattern it is hard to unsee, and it is the single most useful filter we can offer for this entire category: ask whether the proven claim is about a number in your blood or about something that happened to you.
What about the survey the benefits are based on?
They disclose it, which is genuinely better than not disclosing it, and it still is not evidence. The site lists outcomes including better energy, healthier mood and overall improved health, each marked with a dagger. The dagger resolves to: "Based on a survey with 6,243 fatty customers." Six thousand people is a large number and it sounds substantial, but consider who they are. They are people who already believed enough to buy, who spent money, who continued long enough to be surveyed, and who were asked by the company that sold to them whether they felt better. Every one of those filters selects for positive responses. People who tried it, felt nothing and stopped are not in the sample. People who felt worse are not in the sample. And self-reported wellbeing after spending $119.95 on something described as correcting a deficiency is exactly the situation where expectation shapes the answer — this is why placebo controls exist and why open-label surveys are not accepted as efficacy evidence for anything. To be clear about the standard we are applying: we are not demanding a large randomised trial before anyone may sell a supplement. We are saying that when a company presents outcome claims, the dagger should lead somewhere better than a customer poll, and readers should treat surveyed satisfaction as marketing rather than as a finding. The company deserves real credit for footnoting it honestly. It just means the honest footnote tells you the claims are not supported the way they appear to be.
They sell a test for the deficiency too?
Yes, and it is worth seeing that structure plainly. Their range includes a C15:0 diagnostic test alongside the supplement, and the site invites readers to "read the science behind nutritional C15:0 deficiencies." So the sequence available to a customer is: learn that a newly identified essential nutrient exists, learn that being low in it may make your cells fragile and accelerate aging, buy a test to find out whether you are low, and buy the supplement that raises the number. Each step is individually reasonable-sounding and the combination is a closed loop in which the company defines the condition, sells the measurement and sells the remedy. This is not unique to them — it is a recognisable pattern across wellness testing — but it deserves naming, particularly because the underlying classification is contested. If C15:0 is not an established essential nutrient with a defined deficiency state, then a test result telling you your level is low is telling you something whose clinical meaning is unsettled. Low compared to what reference range, established by whom, associated with what outcome? Those are the questions to ask before paying for a number. Our general view on direct-to-consumer testing has not changed: a test is worth buying when the result would change what you do and when there is an agreed interpretation of the result. Here the second condition is not clearly met, and the party offering the interpretation also sells the fix.
Does any of this matter on a GLP-1?
Marginally, and mostly as a caution about where your money goes. There is a thin thread of genuine relevance: C15:0's main dietary source is dairy fat, and people eating substantially less overall — which describes most people on these medicines — will consume less of most things, including this. If C15:0 mattered the way the marketing implies, a shrinking diet would be a reasonable prompt to think about it. But that argument only works if the premise holds, and the premise is exactly what has not been established: there is no recognised deficiency syndrome, no reference intake, and no consensus that C15:0 is essential. The much more concrete point is opportunity cost. At the discounted $119.95 for ninety days, this runs to roughly $487 a year, and the gummies are $79.95. On a medication where the genuine, well-documented nutritional problems are getting adequate protein into a collapsed appetite, staying hydrated when thirst signals fail, and managing fibre for constipation, $487 buys a great deal of protein, several dietitian consultations, or a year of gym membership to protect the lean mass you are actually at risk of losing. Those interventions have real evidence behind them. If you have money earmarked for supporting your body through this, we would spend it there first. And whatever you decide, tell your prescriber what you are taking, because that is the general rule and it costs nothing.
Is it safe?
We have no reason to think otherwise, and that is a genuinely different question from whether it works. C15:0 is a fatty acid present in ordinary foods, principally dairy fat, and taking a purified form of a dietary fatty acid is not intrinsically alarming in the way that, say, a serotonergic botanical or a wild-harvested cyanobacterium is. The FDA disclaimer is present and correctly worded in their footer — "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease" — and we went looking for its absence rather than assuming its presence. We found no FDA warning letter naming the brand. So our criticism throughout this review is about claims and value, not about hazard. Two caveats worth stating anyway. We did not locate a certificate of analysis or contaminant panel, which is ordinary for the category and still a gap. And the children's product gives us more pause than the adult one: a $64.95 supplement of a nutrient with no established paediatric requirement, no reference intake and no recognised deficiency state is a harder purchase to justify, and decisions about supplementing children belong with a paediatrician rather than with a website. If you want to try the adult version because you find the research interesting and can afford it, we would not tell you it is dangerous. We would tell you that you are funding an interesting hypothesis rather than correcting a deficit.
What is your verdict?
2.4 out of 5 — a real molecule and a real research programme, wrapped in a classification that nutrition science has not made. Start with the credit, because there is more of it here than the rating suggests. The FDA disclaimer is present and correctly worded. The benefit claims carry a dagger and the dagger honestly says "Based on a survey with 6,243 fatty customers" rather than implying a trial. The headline efficacy claim, "clinically proven to raise C15:0 levels", is technically accurate and carefully limited — a less scrupulous company would have claimed the outcome rather than the mechanism. There are published patents and studies pages, the origin in US Navy dolphin research is stated rather than obscured, and C15:0 itself is a genuine fatty acid with a growing literature that we are not dismissing. Now the problem, which is one word. "C15:0 is the first essential fatty acid to emerge in over 90 years." In nutrition, essential means the body cannot make enough and absence produces a defined deficiency syndrome — the reason linoleic and alpha-linolenic acid hold that status while even EPA and DHA generally do not. No reference intake body has classified C15:0 as essential, there is no established deficiency state, and there is no reference intake. That single word converts a discretionary purchase into the correction of a deficit you did not know you had, and it is reinforced by invitations to read about "nutritional C15:0 deficiencies" and warnings that low levels make cells "more fragile." Underneath it, the proven claim is that swallowing C15:0 raises your C15:0 — the third time in a short run of reviews we have found a company proving a number moves and letting the reader supply the benefit. Add a diagnostic test sold by the same company that defines the deficiency, patent and study counts presented as though they demonstrate efficacy, roughly $487 a year, and a $64.95 children's version for a nutrient with no paediatric requirement, and the picture is clear enough. It is probably harmless. It is not established as necessary. Our disclosure: 8% commission, about $9.60 on the $119.95 kit, and nothing on our advice to spend it on protein instead.
Ask What The Proof Is Actually Of.
Proven to raise C15:0 levels means swallowing C15:0 puts C15:0 in your blood. Before spending $487 a year, ask whether the proven claim is about a number — or about something that happened to you.
Visit fatty15Compare Other GLP-1 Providers
See how other telehealth providers stack up.
Alan Meds
Top RatedAffordable compounded GLP-1s with board-certified physicians and straightforward pricing
Read Review →PlushCare
Insurance AcceptedMajor telehealth platform with brand-name FDA-approved GLP-1s, insurance support, and 1M+ members treated
Read Review →CoreAge Rx
#1 RecommendedFlat-rate pricing for compounded semaglutide and tirzepatide with NABP-verified pharmacies
Read Review →Mochi Health
Obesity Medicine SpecialistsBoard-certified obesity medicine specialists with both brand-name and compounded GLP-1 options
Read Review →Form Health
Comprehensive ProgramMultidisciplinary obesity medicine program with physicians, dietitians, and behavioral coaching
Read Review →GoodRx Care
Trusted BrandTelehealth platform from GoodRx with transparent pricing and established trust
Read Review →Medical Disclaimer: This page is informational and is neither medical nor nutritional advice. fatty15 sells a dietary supplement; as the company itself states, these statements have not been evaluated by the Food and Drug Administration and the product is not intended to diagnose, treat, cure or prevent any disease. Our discussion of the term essential fatty acid concerns nutritional classification and the state of scientific consensus as we understand it; it is not a claim that C15:0 is useless, harmful or without a legitimate research literature, and readers interested in the underlying science should consult that literature and a qualified clinician or registered dietitian rather than relying on this page. Nothing here should be taken as advice to start or avoid any supplement. Do not give supplements to children without discussing it with a paediatrician, particularly for nutrients with no established paediatric requirement. Direct-to-consumer testing can produce results whose clinical meaning is unsettled and which may cause unnecessary worry or unnecessary purchases; discuss any test result with a clinician who knows your history. Tell every clinician treating you about all supplements you take, particularly alongside a GLP-1 receptor agonist. Guidance on protein intake and resistance training is general and should be individualised by a clinician, dietitian or physiotherapist; protein requirements are affected by kidney function and other conditions. Consult a licensed clinician before starting or changing any treatment.
Date reviewed: 10 August 2026. Prices and product names were read from the store's public structured product data on that date, which listed 22 products including Fatty15 Gummies for Adults at $79.95, Fatty15 Gummies for Kids at $64.95, a fatty15 Starter Kit 90-day Supply at $149.94, travel tins at $15.00, a tote bag at $20.00 and branded t-shirts at $35.00. The homepage displayed the 90-day starter kit at $149.94 struck through to $119.95; the annualised figure of approximately $487 is our own arithmetic from that discounted price applied across four ninety-day periods, and actual pricing may vary with subscription or promotion. Claims quoted verbatim from the company's homepage: 'C15:0 is the first essential fatty acid to emerge in over 90 years'; 'Studies support that low C15:0 levels can make our cells more fragile and may accelerate aging'; 'Read the science behind nutritional C15:0 deficiencies'; 'Fatty15 isn't just a supplement. It is a restoration. By delivering pure, bioavailable C15:0, fatty15 is clinically proven to raise C15:0 levels'; and, appended to a list of claimed outcomes including better energy, healthier mood and overall improved health, the footnote '† Based on a survey with 6,243 fatty customers.' The homepage also displayed '30+ Awards', '100+ Peer-Reviewed Studies' described as 'studies in top-tier journals reinforce scientific credibility', '60+ Patents', and a reference to 'a decade of collaboration with the U.S. Navy'. Site navigation listed a C15:0 Diagnostic Test, a Patents page, a Peer-Reviewed Studies page and a reference to 'The Fatty15 Test by Genova'. The site footer carries the disclaimer 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease', which we specifically checked for and confirmed present. Keyword counts across the 22 product listings are ours: 'C15:0' 13 occurrences, 'essential fatty acid' 3, 'dolphin' 2, 'patent' 2, and zero milligram amounts. Statements that a nutrient is classified as essential only where the body cannot synthesise adequate amounts and absence produces a defined deficiency syndrome, that linoleic acid and alpha-linolenic acid are the established essential fatty acids for humans, that EPA and DHA are generally described as conditionally essential, and that C15:0 occurs in dairy fat, are general nutritional science offered as consumer context; they are not claims made by the retailer, and our statement that no dietary reference intake body has classified C15:0 as essential reflects our understanding of current consensus rather than an exhaustive regulatory search, which we did not perform in this session. Limitations: we did not read the company's patents or peer-reviewed studies pages in detail, did not assess the design, size, funding or findings of any individual study, did not locate a certificate of analysis or contaminant panel, and did not purchase, receive or test any product. We identified no FDA warning letter naming the brand, but did not perform an exhaustive regulatory database search. Katalys offer #1559 lists 8.00% default commission.
Affiliate Disclosure: This site may receive compensation from affiliate partners. This programme pays 8% of order value, roughly $9.60 on the $119.95 ninety-day kit. Our recommendation is that money earmarked for supporting your body during GLP-1 treatment is better spent on protein, dietitian time or resistance training, none of which earns us anything. This does not influence our editorial content or review ratings.